<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="MAPK pathway in congenital thyroid cancer" Version="20200505" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">The MAPK pathway involved in the progression of different diseases such as diabetes, developmental abnormalities and cancer since it has a essential role in the regulation a wide variety of cellular processes such as proliferation, differentiation and apoptosis. consequently, dysregulation of MAPK pathway leads to the occurrence of the related disease </Comment>
  <Graphics BoardWidth="1189.0" BoardHeight="893.0"/>
  <DataNode TextLabel="KSR1" GraphId="d1483" Type="GeneProduct">
    <BiopaxRef>f7f</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="MAP2K2" GraphId="e6973" Type="GeneProduct" GroupRef="cbf39">
        </DataNode>
  <DataNode TextLabel="ELK1" Type="GeneProduct" GroupRef="bc8d6">
        </DataNode>
  <DataNode TextLabel="c-FOS" Type="GeneProduct" GroupRef="bc8d6">
        </DataNode>
  <DataNode TextLabel="c-MYC" Type="GeneProduct" GroupRef="bc8d6">
        </DataNode>
  <DataNode TextLabel="c-JUN" Type="GeneProduct" GroupRef="bc8d6">
        </DataNode>
  <DataNode TextLabel="CRAF&#10;" GraphId="d092c" Type="GeneProduct" GroupRef="fbecc">
        </DataNode>
  <DataNode TextLabel="&#10;RAS&#10;" GraphId="a29e8" Type="Protein" GroupRef="bd43e">
    <Comment>RAS protein has three isoforms ( K,N and H RAS). the isoforms differ in ability of activating RAF protein, the isoform which is responsable the most of activating of Raf protein is Kras&gt; also, HRAS has the ability of activating the RAF proteins but less efficiently than KRAS. (PMID: 9727023)</Comment>
    <BiopaxRef>fb4</BiopaxRef>
    <BiopaxRef>b2b</BiopaxRef>
    <BiopaxRef>e37</BiopaxRef>
    <BiopaxRef>d95</BiopaxRef>
    <BiopaxRef>c70</BiopaxRef>
    <BiopaxRef>de3</BiopaxRef>
    <BiopaxRef>f77</BiopaxRef>
    <BiopaxRef>f6a</BiopaxRef>
    <BiopaxRef>e0d</BiopaxRef>
    <BiopaxRef>be4</BiopaxRef>
    <BiopaxRef>c2b</BiopaxRef>
    <BiopaxRef>c8a</BiopaxRef>
    <BiopaxRef>e23</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="GTP" GraphId="df196" Type="Metabolite" GroupRef="bd43e">
    <Graphics Color="0066cc"/>
    </DataNode>
  <DataNode TextLabel="MAP2K1" GraphId="ce403" Type="GeneProduct" GroupRef="cbf39">
    <BiopaxRef>cb0</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="SOS2" GraphId="f7be1" Type="GeneProduct" GroupRef="dce4d">
    <BiopaxRef>a6e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="MAPK3" GraphId="fc2a0" Type="GeneProduct">
    <Comment>Also known as ERK</Comment>
    <Comment>Type your comment here</Comment>
    <BiopaxRef>cff</BiopaxRef>
    <BiopaxRef>cb0</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="ALK tyrosine kinase receptor" GraphId="ceb27" Type="Protein">
    <BiopaxRef>a6e</BiopaxRef>
    <BiopaxRef>a0b</BiopaxRef>
    <BiopaxRef>ac7</BiopaxRef>
    <BiopaxRef>c6d</BiopaxRef>
    <BiopaxRef>b10</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="GDP" GraphId="de31e" Type="Metabolite" GroupRef="bd43e">
    <Graphics Color="0066ff"/>
    </DataNode>
  <DataNode TextLabel="MAPK3&#10;&#10;" GraphId="ebdd2" Type="GeneProduct">
    <Comment>Also known as ERK</Comment>
    <BiopaxRef>cff</BiopaxRef>
    <BiopaxRef>cb0</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="SHC1" GraphId="fdc59" Type="GeneProduct">
    <BiopaxRef>a0b</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="BRAF" GraphId="fae2d" Type="GeneProduct" GroupRef="fbecc">
    <BiopaxRef>f00</BiopaxRef>
    <BiopaxRef>cff</BiopaxRef>
    <BiopaxRef>aee</BiopaxRef>
    <BiopaxRef>b30</BiopaxRef>
    <BiopaxRef>cb0</BiopaxRef>
    <BiopaxRef>d6b</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="SOS1" GraphId="e1fa5" Type="GeneProduct" GroupRef="dce4d">
    <BiopaxRef>a6e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="GRB2" GraphId="ef02e" Type="Protein">
    <BiopaxRef>a0b</BiopaxRef>
        </DataNode>
  <Interaction GraphId="id162d3abe">
    <BiopaxRef>f00</BiopaxRef>
    <BiopaxRef>f7f</BiopaxRef>
    <Graphics>
      <Point GraphRef="d1483"/>
      <Point GraphRef="dd05c" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a014d">
    <BiopaxRef>a0b</BiopaxRef>
    <BiopaxRef>a6e</BiopaxRef>
    <Graphics>
      <Point GraphRef="ceb27"/>
      <Point GraphRef="ef02e" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bf41b">
    <BiopaxRef>a6e</BiopaxRef>
    <BiopaxRef>e23</BiopaxRef>
    <Graphics>
      <Point GraphRef="ef02e"/>
      <Point GraphRef="fc753" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ae463">
    <BiopaxRef>a6e</BiopaxRef>
    <BiopaxRef>e02</BiopaxRef>
    <BiopaxRef>f00</BiopaxRef>
    <Graphics>
      <Point GraphRef="a4811"/>
      <Point GraphRef="a6c04" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c1218">
    <BiopaxRef>e23</BiopaxRef>
    <BiopaxRef>e3c</BiopaxRef>
    <Graphics>
      <Point GraphRef="de31e"/>
      <Point GraphRef="df196" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="b331e"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e2098">
    <BiopaxRef>a6e</BiopaxRef>
    <BiopaxRef>e02</BiopaxRef>
    <BiopaxRef>f00</BiopaxRef>
    <Graphics>
      <Point GraphRef="a6c04"/>
      <Point GraphRef="fc2a0" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f1fe4">
    <BiopaxRef>a6e</BiopaxRef>
    <BiopaxRef>e23</BiopaxRef>
    <BiopaxRef>faa</BiopaxRef>
    <Graphics>
      <Point GraphRef="fc753"/>
      <Point GraphRef="b331e" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="efac0">
    <BiopaxRef>acf</BiopaxRef>
    <BiopaxRef>cff</BiopaxRef>
    <Graphics>
      <Point GraphRef="fc2a0"/>
      <Point GraphRef="fae2d" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a008c">
    <BiopaxRef>f00</BiopaxRef>
    <BiopaxRef>acf</BiopaxRef>
    <Graphics>
      <Point GraphRef="a29e8"/>
      <Point GraphRef="d092c" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aa9c2">
    <BiopaxRef>a6e</BiopaxRef>
    <BiopaxRef>e02</BiopaxRef>
    <Graphics>
      <Point GraphRef="ebdd2"/>
      <Point GraphRef="c9f6b" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ce16a">
    <BiopaxRef>a6e</BiopaxRef>
    <BiopaxRef>e02</BiopaxRef>
    <Graphics>
      <Point GraphRef="fc2a0"/>
      <Point GraphRef="ebdd2" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b0783">
    <BiopaxRef>a0b</BiopaxRef>
    <BiopaxRef>a6e</BiopaxRef>
    <Graphics>
      <Point GraphRef="ceb27"/>
      <Point GraphRef="fdc59" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b8cef">
    <BiopaxRef>f00</BiopaxRef>
    <BiopaxRef>acf</BiopaxRef>
    <Graphics>
      <Point GraphRef="a29e8"/>
      <Point GraphRef="fae2d" ArrowHead="mim-stimulation"/>
      <Anchor Position="0.4" Shape="None" GraphId="dd05c"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f535f">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="fc2a0"/>
      <Point/>
      <Point GraphRef="ef02e" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Label TextLabel="Nucleus" GraphId="d194d">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Cytoplasm" GraphId="d86d2">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Shape GraphId="e4bb8">
    <Graphics ShapeType="Oval" Color="c0c0c0"/>
  </Shape>
  <Shape GraphId="f758a">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Group GroupId="fbecc" GraphId="a4811" Style="Group">
    <BiopaxRef>f13</BiopaxRef>
    <BiopaxRef>c78</BiopaxRef>
    <BiopaxRef>d8c</BiopaxRef>
  </Group>
  <Group GroupId="cbf39" GraphId="a6c04" Style="Group"/>
  <Group GroupId="bc8d6" GraphId="c9f6b" Style="Group">
    <BiopaxRef>cb0</BiopaxRef>
    <BiopaxRef>a6e</BiopaxRef>
    <BiopaxRef>e02</BiopaxRef>
  </Group>
  <Group GroupId="bd43e" GraphId="fc294" Style="Group">
    <BiopaxRef>e3c</BiopaxRef>
  </Group>
  <Group GroupId="dce4d" GraphId="fc753" Style="Group"/>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f6a">
      <bp:ID >10468914</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Prevalence of Ras mutations in thyroid neoplasia.</bp:TITLE>
      <bp:SOURCE >Clin Endocrinol (Oxf)</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Esapa CT</bp:AUTHORS>
      <bp:AUTHORS >Johnson SJ</bp:AUTHORS>
      <bp:AUTHORS >Kendall-Taylor P</bp:AUTHORS>
      <bp:AUTHORS >Lennard TW</bp:AUTHORS>
      <bp:AUTHORS >Harris PE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f13">
      <bp:ID >6308607</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1983</bp:YEAR>
      <bp:AUTHORS >Rapp UR</bp:AUTHORS>
      <bp:AUTHORS >Goldsborough MD</bp:AUTHORS>
      <bp:AUTHORS >Mark GE</bp:AUTHORS>
      <bp:AUTHORS >Bonner TI</bp:AUTHORS>
      <bp:AUTHORS >Groffen J</bp:AUTHORS>
      <bp:AUTHORS >Reynolds FH Jr</bp:AUTHORS>
      <bp:AUTHORS >Stephenson JR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a0b">
      <bp:ID >15982921</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >RET tyrosine kinase signaling in development and cancer.</bp:TITLE>
      <bp:SOURCE >Cytokine Growth Factor Rev</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Arighi E</bp:AUTHORS>
      <bp:AUTHORS >Borrello MG</bp:AUTHORS>
      <bp:AUTHORS >Sariola H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e3c">
      <bp:ID >17540168</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >GEFs and GAPs: critical elements in the control of small G proteins.</bp:TITLE>
      <bp:SOURCE >Cell</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Bos JL</bp:AUTHORS>
      <bp:AUTHORS >Rehmann H</bp:AUTHORS>
      <bp:AUTHORS >Wittinghofer A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e0d">
      <bp:ID >12866375</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.</bp:TITLE>
      <bp:SOURCE >Am J Clin Pathol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Zhu Z</bp:AUTHORS>
      <bp:AUTHORS >Gandhi M</bp:AUTHORS>
      <bp:AUTHORS >Nikiforova MN</bp:AUTHORS>
      <bp:AUTHORS >Fischer AH</bp:AUTHORS>
      <bp:AUTHORS >Nikiforov YE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ac7">
      <bp:ID >12114746</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >RET/PTC rearrangement in thyroid tumors.</bp:TITLE>
      <bp:SOURCE >Endocr Pathol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Nikiforov YE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b2b">
      <bp:ID >21924373</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Ras trafficking, localization and compartmentalized signalling.</bp:TITLE>
      <bp:SOURCE >Semin Cell Dev Biol</bp:SOURCE>
      <bp:YEAR >2012</bp:YEAR>
      <bp:AUTHORS >Prior IA</bp:AUTHORS>
      <bp:AUTHORS >Hancock JF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c6d">
      <bp:ID >10646883</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Gene rearrangement and Chernobyl related thyroid cancers.</bp:TITLE>
      <bp:SOURCE >Br J Cancer</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Santoro M</bp:AUTHORS>
      <bp:AUTHORS >Thomas GA</bp:AUTHORS>
      <bp:AUTHORS >Vecchio G</bp:AUTHORS>
      <bp:AUTHORS >Williams GH</bp:AUTHORS>
      <bp:AUTHORS >Fusco A</bp:AUTHORS>
      <bp:AUTHORS >Chiappetta G</bp:AUTHORS>
      <bp:AUTHORS >Pozcharskaya V</bp:AUTHORS>
      <bp:AUTHORS >Bogdanova TI</bp:AUTHORS>
      <bp:AUTHORS >Demidchik EP</bp:AUTHORS>
      <bp:AUTHORS >Cherstvoy ED</bp:AUTHORS>
      <bp:AUTHORS >Voscoboinik L</bp:AUTHORS>
      <bp:AUTHORS >Tronko ND</bp:AUTHORS>
      <bp:AUTHORS >Carss A</bp:AUTHORS>
      <bp:AUTHORS >Bunnell H</bp:AUTHORS>
      <bp:AUTHORS >Tonnachera M</bp:AUTHORS>
      <bp:AUTHORS >Parma J</bp:AUTHORS>
      <bp:AUTHORS >Dumont JE</bp:AUTHORS>
      <bp:AUTHORS >Keller G</bp:AUTHORS>
      <bp:AUTHORS >H&#246;fler H</bp:AUTHORS>
      <bp:AUTHORS >Williams ED</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="faa">
      <bp:ID >29610148</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The Interdependent Activation of Son-of-Sevenless and Ras.</bp:TITLE>
      <bp:SOURCE >Cold Spring Harb Perspect Med</bp:SOURCE>
      <bp:YEAR >2019</bp:YEAR>
      <bp:AUTHORS >Bandaru P</bp:AUTHORS>
      <bp:AUTHORS >Kondo Y</bp:AUTHORS>
      <bp:AUTHORS >Kuriyan J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e37">
      <bp:ID >3283542</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The ras gene family and human carcinogenesis.</bp:TITLE>
      <bp:SOURCE >Mutat Res</bp:SOURCE>
      <bp:YEAR >1988</bp:YEAR>
      <bp:AUTHORS >Bos JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d95">
      <bp:ID >22589270</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A comprehensive survey of Ras mutations in cancer.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2012</bp:YEAR>
      <bp:AUTHORS >Prior IA</bp:AUTHORS>
      <bp:AUTHORS >Lewis PD</bp:AUTHORS>
      <bp:AUTHORS >Mattos C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e23">
      <bp:ID >25323927</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Drugging the undruggable RAS: Mission possible?</bp:TITLE>
      <bp:SOURCE >Nat Rev Drug Discov</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Cox AD</bp:AUTHORS>
      <bp:AUTHORS >Fesik SW</bp:AUTHORS>
      <bp:AUTHORS >Kimmelman AC</bp:AUTHORS>
      <bp:AUTHORS >Luo J</bp:AUTHORS>
      <bp:AUTHORS >Der CJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c8a">
      <bp:ID >16785999</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Vitagliano D</bp:AUTHORS>
      <bp:AUTHORS >Portella G</bp:AUTHORS>
      <bp:AUTHORS >Troncone G</bp:AUTHORS>
      <bp:AUTHORS >Francione A</bp:AUTHORS>
      <bp:AUTHORS >Rossi C</bp:AUTHORS>
      <bp:AUTHORS >Bruno A</bp:AUTHORS>
      <bp:AUTHORS >Giorgini A</bp:AUTHORS>
      <bp:AUTHORS >Coluzzi S</bp:AUTHORS>
      <bp:AUTHORS >Nappi TC</bp:AUTHORS>
      <bp:AUTHORS >Rothstein JL</bp:AUTHORS>
      <bp:AUTHORS >Pasquinelli R</bp:AUTHORS>
      <bp:AUTHORS >Chiappetta G</bp:AUTHORS>
      <bp:AUTHORS >Terracciano D</bp:AUTHORS>
      <bp:AUTHORS >Macchia V</bp:AUTHORS>
      <bp:AUTHORS >Melillo RM</bp:AUTHORS>
      <bp:AUTHORS >Fusco A</bp:AUTHORS>
      <bp:AUTHORS >Santoro M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e02">
      <bp:ID >18668205</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The complexity of mitogen-activated protein kinases (MAPKs) made simple.</bp:TITLE>
      <bp:SOURCE >Cell Mol Life Sci</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Krishna M</bp:AUTHORS>
      <bp:AUTHORS >Narang H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c70">
      <bp:ID >9727023</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Yan J</bp:AUTHORS>
      <bp:AUTHORS >Roy S</bp:AUTHORS>
      <bp:AUTHORS >Apolloni A</bp:AUTHORS>
      <bp:AUTHORS >Lane A</bp:AUTHORS>
      <bp:AUTHORS >Hancock JF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb4">
      <bp:ID >17540175</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice.</bp:TITLE>
      <bp:SOURCE >Cell</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Gupta S</bp:AUTHORS>
      <bp:AUTHORS >Ramjaun AR</bp:AUTHORS>
      <bp:AUTHORS >Haiko P</bp:AUTHORS>
      <bp:AUTHORS >Wang Y</bp:AUTHORS>
      <bp:AUTHORS >Warne PH</bp:AUTHORS>
      <bp:AUTHORS >Nicke B</bp:AUTHORS>
      <bp:AUTHORS >Nye E</bp:AUTHORS>
      <bp:AUTHORS >Stamp G</bp:AUTHORS>
      <bp:AUTHORS >Alitalo K</bp:AUTHORS>
      <bp:AUTHORS >Downward J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b10">
      <bp:ID >11278720</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Stoica GE</bp:AUTHORS>
      <bp:AUTHORS >Kuo A</bp:AUTHORS>
      <bp:AUTHORS >Aigner A</bp:AUTHORS>
      <bp:AUTHORS >Sunitha I</bp:AUTHORS>
      <bp:AUTHORS >Souttou B</bp:AUTHORS>
      <bp:AUTHORS >Malerczyk C</bp:AUTHORS>
      <bp:AUTHORS >Caughey DJ</bp:AUTHORS>
      <bp:AUTHORS >Wen D</bp:AUTHORS>
      <bp:AUTHORS >Karavanov A</bp:AUTHORS>
      <bp:AUTHORS >Riegel AT</bp:AUTHORS>
      <bp:AUTHORS >Wellstein A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cb0">
      <bp:ID >15781663</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Mitsutake N</bp:AUTHORS>
      <bp:AUTHORS >Knauf JA</bp:AUTHORS>
      <bp:AUTHORS >Mitsutake S</bp:AUTHORS>
      <bp:AUTHORS >Mesa C Jr</bp:AUTHORS>
      <bp:AUTHORS >Zhang L</bp:AUTHORS>
      <bp:AUTHORS >Fagin JA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a6e">
      <bp:ID >17112607</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The MEK/ERK cascade: from signaling specificity to diverse functions.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Shaul YD</bp:AUTHORS>
      <bp:AUTHORS >Seger R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cff">
      <bp:ID >19933846</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2010</bp:YEAR>
      <bp:AUTHORS >Ritt DA</bp:AUTHORS>
      <bp:AUTHORS >Monson DM</bp:AUTHORS>
      <bp:AUTHORS >Specht SI</bp:AUTHORS>
      <bp:AUTHORS >Morrison DK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d6b">
      <bp:ID >28323937</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.</bp:TITLE>
      <bp:SOURCE >J Clin Endocrinol Metab</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Melo M</bp:AUTHORS>
      <bp:AUTHORS >Gaspar da Rocha A</bp:AUTHORS>
      <bp:AUTHORS >Batista R</bp:AUTHORS>
      <bp:AUTHORS >Vinagre J</bp:AUTHORS>
      <bp:AUTHORS >Martins MJ</bp:AUTHORS>
      <bp:AUTHORS >Costa G</bp:AUTHORS>
      <bp:AUTHORS >Ribeiro C</bp:AUTHORS>
      <bp:AUTHORS >Carrilho F</bp:AUTHORS>
      <bp:AUTHORS >Leite V</bp:AUTHORS>
      <bp:AUTHORS >Lobo C</bp:AUTHORS>
      <bp:AUTHORS >Cameselle-Teijeiro JM</bp:AUTHORS>
      <bp:AUTHORS >Cavadas B</bp:AUTHORS>
      <bp:AUTHORS >Pereira L</bp:AUTHORS>
      <bp:AUTHORS >Sobrinho-Sim&#245;es M</bp:AUTHORS>
      <bp:AUTHORS >Soares P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b30">
      <bp:ID >12670889</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Kimura ET</bp:AUTHORS>
      <bp:AUTHORS >Nikiforova MN</bp:AUTHORS>
      <bp:AUTHORS >Zhu Z</bp:AUTHORS>
      <bp:AUTHORS >Knauf JA</bp:AUTHORS>
      <bp:AUTHORS >Nikiforov YE</bp:AUTHORS>
      <bp:AUTHORS >Fagin JA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="acf">
      <bp:ID >15664191</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of Raf-1 by direct feedback phosphorylation.</bp:TITLE>
      <bp:SOURCE >Mol Cell</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Dougherty MK</bp:AUTHORS>
      <bp:AUTHORS >M&#252;ller J</bp:AUTHORS>
      <bp:AUTHORS >Ritt DA</bp:AUTHORS>
      <bp:AUTHORS >Zhou M</bp:AUTHORS>
      <bp:AUTHORS >Zhou XZ</bp:AUTHORS>
      <bp:AUTHORS >Copeland TD</bp:AUTHORS>
      <bp:AUTHORS >Conrads TP</bp:AUTHORS>
      <bp:AUTHORS >Veenstra TD</bp:AUTHORS>
      <bp:AUTHORS >Lu KP</bp:AUTHORS>
      <bp:AUTHORS >Morrison DK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f7f">
      <bp:ID >29433126</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >MEK drives BRAF activation through allosteric control of KSR proteins.</bp:TITLE>
      <bp:SOURCE >Nature</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Lavoie H</bp:AUTHORS>
      <bp:AUTHORS >Sahmi M</bp:AUTHORS>
      <bp:AUTHORS >Maisonneuve P</bp:AUTHORS>
      <bp:AUTHORS >Marullo SA</bp:AUTHORS>
      <bp:AUTHORS >Thevakumaran N</bp:AUTHORS>
      <bp:AUTHORS >Jin T</bp:AUTHORS>
      <bp:AUTHORS >Kurinov I</bp:AUTHORS>
      <bp:AUTHORS >Sicheri F</bp:AUTHORS>
      <bp:AUTHORS >Therrien M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c78">
      <bp:ID >3043188</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >B-raf, a new member of the raf family, is activated by DNA rearrangement.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >1988</bp:YEAR>
      <bp:AUTHORS >Ikawa S</bp:AUTHORS>
      <bp:AUTHORS >Fukui M</bp:AUTHORS>
      <bp:AUTHORS >Ueyama Y</bp:AUTHORS>
      <bp:AUTHORS >Tamaoki N</bp:AUTHORS>
      <bp:AUTHORS >Yamamoto T</bp:AUTHORS>
      <bp:AUTHORS >Toyoshima K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f77">
      <bp:ID >3283656</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Detection of activated ras oncogenes in human thyroid carcinomas.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >1988</bp:YEAR>
      <bp:ID >3283656</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Detection of activated ras oncogenes in human thyroid carcinomas.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >1988</bp:YEAR>
      <bp:AUTHORS >Su&#225;rez HG</bp:AUTHORS>
      <bp:AUTHORS >Du Villard JA</bp:AUTHORS>
      <bp:AUTHORS >Caillou B</bp:AUTHORS>
      <bp:AUTHORS >Schlumberger M</bp:AUTHORS>
      <bp:AUTHORS >Tubiana M</bp:AUTHORS>
      <bp:AUTHORS >Parmentier C</bp:AUTHORS>
      <bp:AUTHORS >Monier R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c2b">
      <bp:ID >10951588</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Saavedra HI</bp:AUTHORS>
      <bp:AUTHORS >Knauf JA</bp:AUTHORS>
      <bp:AUTHORS >Shirokawa JM</bp:AUTHORS>
      <bp:AUTHORS >Wang J</bp:AUTHORS>
      <bp:AUTHORS >Ouyang B</bp:AUTHORS>
      <bp:AUTHORS >Elisei R</bp:AUTHORS>
      <bp:AUTHORS >Stambrook PJ</bp:AUTHORS>
      <bp:AUTHORS >Fagin JA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f00">
      <bp:ID >25907612</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of RAF protein kinases in ERK signalling.</bp:TITLE>
      <bp:SOURCE >Nat Rev Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2015</bp:YEAR>
      <bp:AUTHORS >Lavoie H</bp:AUTHORS>
      <bp:AUTHORS >Therrien M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="be4">
      <bp:ID >26878173</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >2016</bp:YEAR>
      <bp:AUTHORS >Landa I</bp:AUTHORS>
      <bp:AUTHORS >Ibrahimpasic T</bp:AUTHORS>
      <bp:AUTHORS >Boucai L</bp:AUTHORS>
      <bp:AUTHORS >Sinha R</bp:AUTHORS>
      <bp:AUTHORS >Knauf JA</bp:AUTHORS>
      <bp:AUTHORS >Shah RH</bp:AUTHORS>
      <bp:AUTHORS >Dogan S</bp:AUTHORS>
      <bp:AUTHORS >Ricarte-Filho JC</bp:AUTHORS>
      <bp:AUTHORS >Krishnamoorthy GP</bp:AUTHORS>
      <bp:AUTHORS >Xu B</bp:AUTHORS>
      <bp:AUTHORS >Schultz N</bp:AUTHORS>
      <bp:AUTHORS >Berger MF</bp:AUTHORS>
      <bp:AUTHORS >Sander C</bp:AUTHORS>
      <bp:AUTHORS >Taylor BS</bp:AUTHORS>
      <bp:AUTHORS >Ghossein R</bp:AUTHORS>
      <bp:AUTHORS >Ganly I</bp:AUTHORS>
      <bp:AUTHORS >Fagin JA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d8c">
      <bp:ID >3491291</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Characterization of murine A-raf, a new oncogene related to the v-raf oncogene.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >1986</bp:YEAR>
      <bp:AUTHORS >Huleihel M</bp:AUTHORS>
      <bp:AUTHORS >Goldsborough M</bp:AUTHORS>
      <bp:AUTHORS >Cleveland J</bp:AUTHORS>
      <bp:AUTHORS >Gunnell M</bp:AUTHORS>
      <bp:AUTHORS >Bonner T</bp:AUTHORS>
      <bp:AUTHORS >Rapp UR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de3">
      <bp:ID >11278702</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential activation of the Rac pathway by Ha-Ras and K-Ras.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Walsh AB</bp:AUTHORS>
      <bp:AUTHORS >Bar-Sagi D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aee">
      <bp:ID >14602780</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.</bp:TITLE>
      <bp:SOURCE >J Clin Endocrinol Metab</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Nikiforova MN</bp:AUTHORS>
      <bp:AUTHORS >Kimura ET</bp:AUTHORS>
      <bp:AUTHORS >Gandhi M</bp:AUTHORS>
      <bp:AUTHORS >Biddinger PW</bp:AUTHORS>
      <bp:AUTHORS >Knauf JA</bp:AUTHORS>
      <bp:AUTHORS >Basolo F</bp:AUTHORS>
      <bp:AUTHORS >Zhu Z</bp:AUTHORS>
      <bp:AUTHORS >Giannini R</bp:AUTHORS>
      <bp:AUTHORS >Salvatore G</bp:AUTHORS>
      <bp:AUTHORS >Fusco A</bp:AUTHORS>
      <bp:AUTHORS >Santoro M</bp:AUTHORS>
      <bp:AUTHORS >Fagin JA</bp:AUTHORS>
      <bp:AUTHORS >Nikiforov YE</bp:AUTHORS>
    </bp:PublicationXref>
  <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>altered Erk5 MAPK signaling pathway</bp:TERM><bp:ID>PW:0000604</bp:ID><bp:Ontology>Pathway Ontology</bp:Ontology></bp:openControlledVocabulary><bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>thyroid cancer pathway</bp:TERM><bp:ID>PW:0000698</bp:ID><bp:Ontology>Pathway Ontology</bp:Ontology></bp:openControlledVocabulary><bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>thyroid cancer</bp:TERM><bp:ID>DOID:1781</bp:ID><bp:Ontology>Disease</bp:Ontology></bp:openControlledVocabulary></Biopax>
</Pathway>